HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuli Huang Selected Research

WD repeat containing planar cell polarity effector

1/2020Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease.
1/2020Prognostic Value of Secreted Frizzled-Related Protein 5 in Heart Failure Patients With and Without Type 2 Diabetes Mellitus.
1/2020IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway.
1/2020Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuli Huang Research Topics

Disease

12Heart Failure
01/2022 - 01/2009
10Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 11/2011
8Atrial Fibrillation
01/2022 - 12/2015
8Myocardial Infarction
01/2021 - 01/2009
7Hypertension (High Blood Pressure)
01/2020 - 03/2012
5Glucose Intolerance
01/2021 - 11/2014
5Stroke (Strokes)
01/2020 - 11/2016
5Acute Coronary Syndrome
01/2019 - 04/2017
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 01/2011
4Prediabetic State (Prediabetes)
01/2021 - 11/2014
3Body Weight (Weight, Body)
01/2021 - 02/2012
3Fibrosis (Cirrhosis)
01/2021 - 08/2015
3Overweight
01/2020 - 11/2014
3Dyslipidemias (Dyslipidemia)
01/2020 - 01/2018
3Coronary Disease (Coronary Heart Disease)
01/2020 - 10/2015
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 06/2021
2Neoplasms (Cancer)
01/2022 - 11/2014
2Hemorrhage
01/2022 - 01/2019
2Cardiac Arrhythmias (Arrythmia)
01/2022 - 12/2017
2Chronic Renal Insufficiency
08/2021 - 09/2013
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2020
2Hyperuricemia
01/2020 - 01/2019
2Obesity
01/2020 - 01/2019
2Ischemic Stroke
01/2020 - 01/2019
2Heart Diseases (Heart Disease)
01/2020 - 01/2016
2Inflammation (Inflammations)
11/2017 - 01/2017
1Venous Thromboembolism
01/2022
1Iron Deficiencies
12/2021
1Atherosclerotic Plaque (Atheroma)
08/2021
1Pathologic Constriction (Stenosis)
08/2021
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2021
1COVID-19
01/2021
1ST Elevation Myocardial Infarction
01/2021
1Diabetic Cardiomyopathies
01/2021
1Gestational Diabetes (Gestational Diabetes Mellitus)
01/2021
1Foot Diseases
10/2020
1Cognitive Dysfunction
01/2020
1Nasopharyngeal Carcinoma
01/2020
1Masked Hypertension
01/2020
1Diabetes Mellitus
01/2020
1Aortic Valve Stenosis (Aortic Stenosis)
01/2020
1Hypotension (Low Blood Pressure)
01/2020
1Infarction (Infarctions)
01/2020
1White Coat Hypertension
01/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Nervous System Diseases (Neurological Disorders)
01/2020
1Parkinson Disease (Parkinson's Disease)
01/2020
1Epilepsy (Aura)
01/2020
1Alzheimer Disease (Alzheimer's Disease)
01/2020
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2020

Drug/Important Bio-Agent (IBA)

10Glucose (Dextrose)FDA LinkGeneric
01/2021 - 11/2014
7Biomarkers (Surrogate Marker)IBA
08/2021 - 01/2020
4C-Reactive ProteinIBA
01/2022 - 03/2013
4WD repeat containing planar cell polarity effectorIBA
01/2020 - 01/2020
4oxidized low density lipoproteinIBA
01/2018 - 01/2011
4Atorvastatin (Lipitor)FDA Link
01/2013 - 11/2011
31-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
08/2021 - 11/2017
2Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2021
2Fibroblast Growth Factor 1 (FGF-1)IBA
01/2021 - 01/2021
24- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA
01/2020 - 01/2020
2Digoxin (Digitek)FDA LinkGeneric
03/2016 - 12/2015
2NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2013 - 11/2012
2plerixaforFDA Link
01/2013 - 11/2012
2Brain Natriuretic Peptide (Natrecor)FDA Link
11/2011 - 01/2009
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1Ferritins (Ferritin)IBA
12/2021
1Uric Acid (Urate)IBA
06/2021
1CreatinineIBA
01/2021
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2021
1CanagliflozinIBA
01/2021
1SodiumIBA
01/2021
1DiureticsIBA
01/2021
1AlbuminsIBA
01/2021
1alpha-Linolenic Acid (Linolenic Acid)IBA
01/2021
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2021
1trimethyloxamine (trimethylamine N-oxide)IBA
10/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2020
1AdipokinesIBA
01/2020
1Plant ExtractsIBA
01/2020
1CateninsIBA
01/2020
1Secreted Frizzled-Related ProteinsIBA
01/2020
1Glutamic Acid (Glutamate)FDA Link
01/2020
1AnticoagulantsIBA
01/2019
1Vitamin KFDA Link
01/2019
1bivalirudin (Angiomax)FDA Link
01/2019
1Warfarin (Coumadin)FDA LinkGeneric
01/2019
1RivaroxabanIBA
11/2018
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2018

Therapy/Procedure

8Therapeutics
01/2021 - 12/2015
3Percutaneous Coronary Intervention
01/2021 - 04/2017
2Secondary Prevention
01/2022 - 01/2020
2Transplantation
01/2020 - 11/2011
1Radiofrequency Ablation
01/2022
1Catheter Ablation
01/2022
1Surgical Amputation (Amputations)
10/2020
1Transcatheter Aortic Valve Replacement
01/2020
1Patient Readmission
01/2020
1Electric Countershock (Cardioversion)
12/2017